SEATTLE, WA / ACCESSWIRE / September 18, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...
New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September ...
BioMed X, a German biomedical research institute, announced the start of a new research team at the BioMed X Institute in ...
ISTANBUL, TURKEY / ACCESSWIRE / September 18, 2024 / Afro Hair Transplant Clinic is proud to announce its recognition as one of the Top 10 Hair Transplant Clinics in Istanbul for 2024. Renowned for ...
HOUSTON, TX / ACCESSWIRE / September 18, 2024 / Mann Eye Institute, a leading provider of comprehensive eye care services in Texas, is proud to announce its 47th anniversary. Founded on October 31, ...
FIRST COLLABORATIVE EFFORT UNDER NEW AGREEMENT ALLEN, TX / ACCESSWIRE / September 18, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Department of ...
The rebrand reinforces the company's commitment to simplifying healthcare administration and streamlining credentialing to help providers focus on patient care.AUSTIN, TX / ACCESSWIRE / September 18, ...
REDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based ...
Partnership enables an integration to improve the productivity of clinical development team. SAN DIEGO, September 18, 2024 (Newswire.com) - Faro Health Inc., the leading AI-powered platform for ...
Allowed claims cover major features of pumping mechanism in FDA-cleared MODD1 productSAN DIEGO, CA / ACCESSWIRE / September 18, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the ...
STONY BROOK, NY / ACCESSWIRE / September 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on September 17, 2024, it ...